Prelude Fertility IncReproductive Endocrinologist - Franklin, Tennessee Prelude Fertility IncReproductive Endocrinologist - Franklin, TennesseeFranklin, TNOur team comprises top-rated and award-winning fertility specialists who share a unified goal: to help create and grow families, one healthy baby at a time, while offering compassionate care at every stage of the patient journey. The fertility physicians across our network have earned over 400 prestigious awards, including Super Doctors, Castle Connolly's National "Top Doctors", America's Top Obstetrics and Gynecologists, and more.
Taylor Strategy PartnersSpecialty Sales Representative – Cardiometabolic Rare Disease Taylor Strategy PartnersSpecialty Sales Representative – Cardiometabolic Rare DiseaseNashville, TNRemote$160,000–$178,000 / yearThis is a unique opportunity to play a meaningful role in the launch and growth of our cardiometabolic portfolio, including Plozasiran (siRNA targeting APOC3), developed for patients with rare and high-need cardiovascular conditions such as Familial Chylomicronemia Syndrome (FCS) and Severe Hypertriglyceridemia (SHTG). Arrowhead is leading the field in bringing the promise of RNAi to address diseases outside of the liver, and our clinical pipeline includes disease targets in the liver and lung with a promising pipeline of preclinical candidates.
Taylor Strategy PartnersNewSpecialty Sales Representative - Cardiometabolic Rare Disease Taylor Strategy PartnersSpecialty Sales Representative - Cardiometabolic Rare DiseaseMemphis, TNRemote$160,000–$180,000 / yearThis is a unique opportunity to play a meaningful role in the launch and growth of our cardiometabolic portfolio, including Plozasiran (siRNA targeting APOC3), developed for patients with rare and high-need cardiovascular conditions such as Familial Chylomicronemia Syndrome (FCS) and Severe Hypertriglyceridemia (SHTG). Arrowhead is leading the field in bringing the promise of RNAi to address diseases outside of the liver, and our clinical pipeline includes disease targets in the liver and lung with a promising pipeline of preclinical candidates.